Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vi-TCV Safety and Immunogenicity in Children in Burkina Faso
NCT03614533Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2018
- Primary completion
- Aug 2019
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Vi-Typhoid Conjugate Vaccine in typhoid fever, sponsored by University of Maryland, Baltimore. Started Dec 2018; status: completed.
02
Drugs
Vi-Typhoid Conjugate Vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT03614533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614533.